As shown in Table 1, PIK3CA mutations were more likely to be detected in patients over 40 years old (P = 0.002), those who are postmenopausal (P = 0.004), and had ER-positive (P = 0.002), and PR-positive (P = 0.012) types of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.